Article · 30 Jan 2025
Research articlePublished 12 Apr 2020
Efficacy and safety of Livwin (polyherbal formulation) in patients with acute viral hepatitis: A controlled clinical trial
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
The study was planned to evaluate the efficacy and safety of Livwin (polyherbal formulation) in acute viral hepatitis. In this study, there were 29 patients in each group, receiving either Livwin or placebo. Livwin capsules contains Terminalia arjuna - 100 mg, Withania somnifera – 100 mg, Phyllanthus niruri - 100 mg, Berberis aristata – 50 mg, Tinospora cordofolia – 75 mg, Picrorhiza kurroa – 50 mg, Boerhaavia diffusa – 50 mg. Placebo capsules contains lactose 500 mg. Both drugs were given orally, two capsules 2 times a day for 8 weeks followed by treatment free period of 4 weeks. Recovery of patients assessed by clinical parameters: fever, weakness, icterus and tender, enlarged liver and by biochemical parameters: serum bilirubin, SGOT (Serum glutamate oxaloacetate transaminase), SGPT (Serum glutamate pyruvate transaminase), serum alkaline phosphatase at baseline, 2 weeks, 4 weeks, 8 weeks and 12 weeks. Significant clinical recovery was observed in the form of icterus and weakness with Livwin as compared to placebo at 2 and 4 weeks (P < 0.001). There was significant reduction in mean levels of serum bilirubin, SGOT and SGPT at 2 weeks, 4 weeks, and 8 weeks with Livwin as compared with placebo (P < 0.001). Significant reduction in mean levels of serum alkaline phosphatase with Livwin at 2 weeks (P < 0.01) and 4 weeks (P < 0.05) as compared with placebo. Mean serum bilirubin reduced by 6.72 mg/dl with Livwin and with placebo reduced by 3.64 mg/dl at 2 weeks (P < 0.001). Mean SGOT reduced by 609.11 IU/ L with Livwin and with placebo reduced by 240.34 IU/L at 2 weeks (P < 0.001). Mean SGPT reduced by 920.65 IU/L with Livwin and with placebo reduced by 326.96 IU/L at 2 weeks (P < 0.001). Livwin had shown good efficacy in patients of acute viral hepatitis. Adverse events like epigastric pain and diarrhoea were recorded with Livwin treatment and were not significant as compared to placebo.
Subjects
Social Sciences & HumanitiesAsk about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
More from this journal
The newest in International Journal of Medical Sociology and Anthropology.
Article · 5 Aug 2024
The significance of cultural competency in healthcare: A medical anthropology perspective
Article · 5 Aug 2024
Echoes of the past: Unearthing the foundations of human civilization
Conferences in this field
Upcoming conferences in this field.
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalInternational Journal of Medical Sociology and Anthropology
- SubjectSocial Sciences & Humanities
- BylineArticles whose byline prints “Yogendra N. Keche”
- BylineArticles whose byline prints “Vandana A. Badar”
- BylineArticles whose byline prints “Mrunalini M. Hardas”